Article

Advances in Cancer Drug Development Highlights Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/advances-in-cancer-drug-development-highlights-spe" target="_blank">View the story "Advances in Cancer Drug Development Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
The FDA approved meloxicam and rizatriptan (Symbravo; Axsome Therapeutics Inc) for the acute treatment of migraine, either with or without aura | Image Credit: goodluz | stock.adobe.com
January 30th 2025

FDA Approves Symbravo for Acute Treatment of Migraine With or Without Aura

Ashley Gallagher, Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Coronavirus molecules.
January 29th 2025

Common Osteoporosis Treatments May Offer Protection Against COVID-19

Luke Halpern, Assistant Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Progress pride flag -- Image credit: Marcela Ruty Romero | stock.adobe.com
January 29th 2025

Understanding Gender-Affirmative Care Beyond Women’s Health

Rachel Chandra, PharmD, MPH, FASHP
Advances in Dermatomyositis Treatment
January 28th 2025

Patients With Juvenile Dermatomyositis Treated With IVIG Had No Increased Risk of Thromboembolic Events

Luke Halpern, Assistant Editor